Millipore Sigma Vibrant Logo

341599 FGF-10, Human, Recombinant

FGF-10, Human, Recombinant MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
View Products on Sigmaaldrich.com
341599
  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited Availability Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Purity
      ≥97% by SDS-PAGE
      Description
      OverviewRecombinant, human fibroblast growth factor 10 (FGF-10) consisting of amino acids 137-208 and expressed in E. Coli. Mature human FGF-10, a ~20 kDa protein, contains a serine-rich region near its N-terminus sharing 93% amino acid sequence identity with mouse FGF-10 and 96% with rat FGF-10.
      Catalogue Number341599
      Brand Family Calbiochem®
      References
      ReferencesBeenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.
      Product Information
      FormLiquid
      FormulationLyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells.
      Purity≥97% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      341599 0

      Documentation

      FGF-10, Human, Recombinant SDS

      Title

      Safety Data Sheet (SDS) 

      FGF-10, Human, Recombinant Certificates of Analysis

      TitleLot Number
      341599

      References

      Reference overview
      Beenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-Sepmtember-2011 RFH
      DescriptionRecombinant, human fibroblast growth factor 10 (FGF-10) consisting of amino acids 137-208 and expressed in E. Coli. Mature human FGF-10, a ~20 kDa protein, contains a serine-rich region near its N-terminus sharing 93% amino acid sequence identity with mouse FGF-10 and 96% with rat FGF-10.
      FormLiquid
      FormulationLyophilized from 0.2 µm sterile-filtered MOPS, Na₂SO₄, EDTA, DTT, BSA.
      Purity≥97% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/µg protein
      Biological activityED₅₀ = 20-100 ng/ml measured in a cell proliferation assay using 4MBr-5 monkey epithelial cells.
      SolubilityReconstitute to 100 µg/ml in sterile PBS containing at least 0.1% human or bovine serum albumin.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBeenken, A. and M. Mohammadi. 2009. Nat. Rev. Drug Discov. 8, 235.
      Nomura, S., et al. 2008. Br. J. Cancer 99, 305.
      Zhang, X., et al. 2006. J. Biol. Chem. 281, 15694.
      Beer, H.D., et al. 2005. Oncogene 24, 5269.
      Jaskoll, T., et al. 2005. BMC Dev. Biol. 5, 11.
      Rice, R., et al. 2004. J. Clin. Invest. 113, 1692.
      Donjacour, A.A., et al. 2003. Dev. Biol. 261, 39.
      Mailleux, A.A., et al. 2002. Development 129, 53.
      Sakaue, H., et al. 2002. Genes Dev. 16, 908.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Makarenkova, H.P., et al. 2000. Development 127, 2563.
      Pirvola, U., et al. 2000. J. Neurosci. 20, 6125.
      Weaver, M., et al. 2000. Development 127, 2695.
      Igarashi, M., et al. 1998. J. Biol. Chem. 273, 13230.
      Min, H., et al. 1998. Genes Dev. 12, 3156.
      Bellusci, S., et al. 1997. Development 124, 4867.
      Emoto, H., et al. 1997. J. Biol. Chem. 272, 23191.